J. E. Branka, G. Vallette, A. Jarry, C. Bou-hanna, P. Lemarre et al., Early functional effects of Clostridium difficile toxin A on human colonocytes, Gastroenterology, vol.112, pp.1887-94, 1997.

A. Jarry, C. Bossard, C. Bou-hanna, D. Masson, E. Espaze et al., Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gammamediated epithelial damage in human colon explants, J Clin Invest, vol.118, pp.1132-1174, 2008.

A. Jarry, C. Bossard, G. Sarrabayrouse, J. F. Mosnier, and C. L. Laboisse, Loss of interleukin-10 or transforming growth factor ? signaling in the human colon initiates a T-helper 1 response via distinct pathways, Gastroenterology, vol.141, pp.1887-96, 2011.

A. Jarry, L. Crémet, N. Caroff, C. Bou-hanna, J. M. Mussini et al., Subversion of human intestinal mucosa innate immunity by a Crohn's disease-associated E. coli, Mucosal Immunol, vol.8, pp.572-81, 2015.

A. Jarry, F. Malard, C. Bou-hanna, G. Meurette, M. Mohty et al., Interferon-Alpha Promotes Th1 Response and Epithelial Apoptosis via Inflammasome Activation in Human Intestinal Mucosa, Cell Mol Gastroenterol Hepatol, vol.3, pp.72-81, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01726915

H. M. Lazear, T. J. Nice, and M. S. Diamond, Interferon-?: Immune Functions at Barrier Surfaces and Beyond, Immunity, vol.43, pp.15-28, 2015.

K. Onoguchi, M. Yoneyama, A. Takemura, S. Akira, T. Taniguchi et al., Viral infections activate types I and III interferon genes through a common mechanism, J Biol Chem, vol.282, pp.7576-81, 2007.

S. J. Thomson, F. G. Goh, H. Banks, T. Krausgruber, S. V. Kotenko et al., The role of transposable elements in the regulation of IFN-lambda1 gene expression, Proc Natl Acad Sci, vol.106, pp.11564-11573, 2009.

S. V. Kotenko, G. Gallagher, V. V. Baurin, A. Lewis-antes, M. Shen et al., IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex, Nat Immunol, vol.4, pp.69-77, 2003.

Z. Zhou, O. J. Hamming, N. Ank, S. R. Paludan, A. L. Nielsen et al., Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases, J Virol, vol.81, pp.7749-58, 2007.

A. Lasfar, A. Zloza, A. De-la-torre, and K. A. Cohen-solal, IFN?: A New Inducer of Local Immunity against Cancer and Infections, Front Immunol, vol.7, p.598, 2016.

A. J. Muir, S. Arora, G. Everson, R. Flisiak, J. George et al., and EMERGE study group. A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection, J Hepatol, vol.61, pp.1238-1284, 2014.

A. Lasfar, W. Abushahba, M. Balan, and K. A. Cohen-solal, Interferon lambda: a new sword in cancer immunotherapy, Clin Dev Immunol, vol.13, p.349575, 2011.

A. Stiff and C. W. , Investigations of interferonlambda for the treatment of cancer, J Innate Immun, vol.7, pp.243-50, 2015.

K. Saxena, S. E. Blutt, K. Ettayebi, X. L. Zeng, J. R. Broughman et al., Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology, J Virol, vol.90, pp.43-56, 2015.

K. Saxena, L. M. Simon, X. L. Zeng, S. E. Blutt, S. E. Crawford et al., A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric v irus infection, Proc Natl Acad Sci, vol.114, pp.570-79, 2017.

K. Pervolaraki, M. L. Stanifer, S. Münchau, L. A. Renn, D. Albrecht et al., Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut, Front Immunol, vol.8, p.459, 2017.

F. Weber, V. Wagner, S. B. Rasmussen, R. Hartmann, and S. R. Paludan, Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses, J Virol, vol.80, pp.5059-64, 2006.

N. Takemura, T. Kawasaki, J. Kunisawa, S. Sato, A. Lamichhane et al., Blockade of TLR3 protects mice from lethal radiationinduced gastrointestinal syndrome, Nat Commun, vol.5, p.3492, 2014.

C. S. Mcallister, O. Lakhdari, P. De-chambrun, G. Gareau, M. G. Broquet et al., TLR3, TRIF, and caspase 8 determine doublestranded RNA-induced epithelial cell death and survival in vivo, J Immunol, vol.190, pp.418-445, 2013.

J. M. Williams, C. A. Duckworth, M. D. Burkitt, A. J. Watson, B. J. Campbell et al., Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip, Vet Pathol, vol.52, pp.445-55, 2015.

C. L. Laboisse, C. Augeron, M. H. Couturier-turpin, C. Gespach, A. M. Cheret et al., Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors, Cancer Res, vol.42, pp.1541-1549, 1982.

L. Charrier, A. Jarry, C. Toquet, C. Bou-hanna, M. Chedorge et al., Growth phase-dependent expression of ICAD-L/DFF45 modulates the pattern of apoptosis in human colonic cancer cells, Cancer Res, vol.62, pp.2169-74, 2002.

C. Augeron and C. L. Laboisse, Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate, Cancer Res, vol.44, pp.3961-3970, 1984.

M. Laburthe, C. Augeron, C. Rouyer-fessard, I. Roumagnac, J. J. Maoret et al., Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E, Am J Physiol, vol.256, pp.443-50, 1989.

C. Rouyer-fessard, C. Augeron, E. Grasset, J. J. Maoret, C. L. Laboisse et al., VIP receptors and control of short circuit current in the human intestinal clonal cell line Cl.19A, Experientia, vol.45, pp.1102-1107, 1989.

A. Swider, R. Siegel, J. Eskdale, and G. Gallagher, Regulation of interferon lambda-1 (IFNL1/IFN-?1/IL-29) expression in human colon epithelial cells, Cytokine, vol.65, pp.17-23, 2014.

D. Yu, M. Zhao, L. Dong, L. Zhao, M. Zou et al., Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes, Drug Des Devel Ther, vol.10, pp.163-82, 2016.

K. E. Kehoe, M. A. Brown, and F. Imani, Double-stranded RNA regulates IL-4 expression, J Immunol, vol.167, pp.2496-501, 2001.

J. Qu, Z. Hou, Q. Han, W. Jiang, C. Zhang et al., Intracellular poly(I:C) initiated gastric adenocarcinoma cell apoptosis and subsequently ameliorated NK cell functions, J Interferon Cytokine Res, vol.34, pp.52-61, 2014.

T. Samuel, K. Fadlalla, D. N. Gales, B. D. Putcha, and U. Manne, Variable NF-?B pathway responses in colon cancer cells treated with chemotherapeutic drugs, BMC Cancer, vol.14, p.599, 2014.

H. Panet, A. Barzilai, D. Daily, E. Melamed, and D. Offen, Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells, J Neurochem, vol.77, pp.391-399, 2001.

Y. X. Sun, D. K. Dai, R. Liu, T. Wang, C. L. Luo et al., Therapeutic effect of SN50, an inhibitor of nuclear factor-?B, in treatment of TBI in mice, Neurol Sci, vol.34, pp.345-55, 2013.

X. Zhu, K. Wang, K. Zhang, F. Zhou, and L. Zhu, Induction of oxidative and nitrosative stresses in human retinal pigment epithelial cells by all-trans-retinal, Exp Cell Res, vol.348, pp.87-94, 2016.

M. A. Robbins, L. Maksumova, E. Pocock, and J. K. Chantler, Nuclear factor-kappaB translocation mediates doublestranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL), Endocrinology, vol.144, pp.4616-4641, 2003.

T. R. Torgerson, A. D. Colosia, J. P. Donahue, Y. Z. Lin, and J. Hawiger, Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50, J Immunol, vol.161, pp.6084-92, 1998.

D. T. Le, J. N. Uram, H. Wang, B. R. Bartlett, H. Kemberling et al., , p.1

, Blockade in Tumors with Mismatch-Repair Deficiency, N Engl J Med, vol.372, pp.2509-2529, 2015.

Z. Liu, R. Ravindranathan, P. Kalinski, Z. S. Guo, and D. L. Bartlett, Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy, Nat Commun, vol.8, p.14754, 2017.

C. Myskiw, J. Arsenio, C. Hammett, R. Van-bruggen, Y. Deschambault et al., Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicity, J Virol, vol.85, pp.12280-91, 2011.

R. Maitra, T. Augustine, Y. Dayan, C. Chandy, M. Coffey et al., Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer, Oncotarget, vol.8, pp.35138-53, 2017.

J. Dai, N. J. Megjugorac, G. E. Gallagher, R. Y. Yu, and G. Gallagher, IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells, Blood, vol.113, pp.5829-5867, 2009.

A. Sato, M. Ohtsuki, M. Hata, E. Kobayashi, and T. Murakami, Antitumor activity of IFN-lambda in murine tumor models, J Immunol, vol.176, pp.7686-94, 2006.

F. Souza-fonseca-guimaraes, A. Young, and M. J. Smyth, IFN type III: in vivo NK cell response, Oncotarget, vol.6, pp.19960-61, 2015.

A. M. Salazar, R. B. Erlich, A. Mark, N. Bhardwaj, and R. B. Herberman, Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial, Cancer Immunol Res, vol.2, pp.720-724, 2014.

C. Kyi, V. Roudko, R. Sabado, Y. Saenger, W. Loging et al., Therapeutic Immune Modulation against Solid Cancers with Intratumoral PolyICLC: A Pilot Trial, Clin Cancer Res. Epub ahead of print